Farmington Hills, MI, United States of America

Annise Paige Goodman

This inventor holds 2 USPTO granted patents. Top assignee: Warner-Lambert Company. Active years: 2007-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Annise Paige Goodman. Retrieved from https://idiyas.com/inventor/annise-paige-goodman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2007-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Annise Paige Goodman: Innovator in Amino Acid Research

Introduction

Annise Paige Goodman is a notable inventor based in Farmington Hills, MI (US). She has made significant contributions to the field of amino acid research, holding 2 patents that focus on compounds with therapeutic potential.

Latest Patents

Goodman's latest patents involve amino acids with affinity for the α2δ-protein. These patents disclose certain β-amino acids that bind to the alpha-2-delta (α2δ) subunit of a calcium channel. The compounds and their pharmaceutically acceptable salts are useful in treating a variety of psychiatric, pain, and other disorders. Additionally, the patents outline methods for synthesizing these β-amino acids.

Career Highlights

Annise Paige Goodman is associated with Warner-Lambert Company, where she has been able to apply her innovative ideas in a practical setting. Her work has contributed to advancements in the pharmaceutical industry, particularly in the development of treatments for complex disorders.

Collaborations

Goodman has collaborated with notable colleagues such as Peter Garth Blazecka and Joseph Richard Bozelak. These partnerships have likely enhanced her research and development efforts, leading to impactful innovations.

Conclusion

Annise Paige Goodman stands out as a pioneering inventor in the field of amino acid research, with her patents paving the way for new therapeutic options. Her contributions continue to influence the pharmaceutical landscape and improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…